drugset / Trial / NCT03614975
Immunologic Response to Influenza Vaccination in Children and Adolescents
Phase 4
Completed
166 enrolled
Richard Zimmerman MD
Centers for Disease Control and Prevention · collab
RandomizedParallel-groupOpen-labelPrevention
Summary
The purpose of this study is to evaluate immunologic response to different types of influenza vaccine among children/adolescents/young adults 4-20 years of age. This is a randomized controlled trial (RCT), that will assess immune response in 120 participants (60 per vaccine arm) pre- and post-vaccination to Flucelvax (egg-free inactivated flu shot) and Fluzone (egg-based inactivated flu shot).
Timeline
- Start
- 2018-09-13
- Primary completion
- 2018-12-13
- Completion
- 2018-12-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Flucelvax | Vaccine | 0.5 ml | Intramuscular |
| Comparator | Influenza Virus Vaccine | Vaccine | 0.5 ml | Intramuscular |